These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1789530)

  • 21. Complement and its breakdown products in SLE.
    Sturfelt G; Truedsson L
    Rheumatology (Oxford); 2005 Oct; 44(10):1227-32. PubMed ID: 15972354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arthritis in definitive systemic lupus erythematosus].
    Haberhauer G
    Z Arztl Fortbild (Jena); 1990; 84(3):85-7. PubMed ID: 2343605
    [No Abstract]   [Full Text] [Related]  

  • 23. Perspectives in pediatric systemic lupus erythematosus.
    Ansell BM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():177-9. PubMed ID: 3612646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of antihistone antibody screening in the diagnosis of drug-induced lupus erythematosus.
    Zirwas MJ; Kress DW; Deng JS
    Arch Dermatol; 2004 Apr; 140(4):494-5. PubMed ID: 15096389
    [No Abstract]   [Full Text] [Related]  

  • 25. Usefulness of direct immunofluorescence in patients with lupus erythematosus.
    Dahl MV
    Arch Dermatol; 1983 Dec; 119(12):1010-7. PubMed ID: 6360051
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunofluorescent investigations in the diagnosis of lupus erythematosus.
    Chorzelski T; Blaszczyk M; Jarzabek M
    Pol Med J; 1968; 7(2):479-85. PubMed ID: 4872573
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and subclinical involvement of the central nervous system in systemic lupus erythematosus.
    Denburg JA
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():171-8. PubMed ID: 2326542
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intervention of heparin in immunological phenomena: reversibility of the nuclear antigen and antinuclear antibody reaction in systemic lupus erythematosus].
    Bardare M; Menghi P
    Boll Soc Ital Biol Sper; 1965 Jul; 41(13):713-5. PubMed ID: 4164914
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-dsDNA and complement profiles in systemic lupus erythematosus.
    Swaak AJ; Groenwold J; Bronsveld W; Douma J; Feltkamp TE
    Neth J Med; 1981; 24(4):152-6. PubMed ID: 7024831
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathogenic role of auto-antibodies against complement components in systemic lupus erythematosus.
    Daha MR
    Lupus; 2008 May; 17(5):385-8. PubMed ID: 18490413
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoantibodies in systemic rheumatic disorders clinical and diagnostic relevance.
    Genth E; Mierau R
    Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):149S-152S. PubMed ID: 9385666
    [No Abstract]   [Full Text] [Related]  

  • 33. [Systemic lupus erythematosus: diagnostic criteria].
    Schifferli JA
    Schweiz Rundsch Med Prax; 1987 Dec; 76(51):1417-9. PubMed ID: 3438633
    [No Abstract]   [Full Text] [Related]  

  • 34. [New criteria for the diagnosis of systemic lupus erythematosus].
    Font J; Cardellach F
    Med Clin (Barc); 1984 Jun; 83(3):109-11. PubMed ID: 6332956
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N; Haustein UF; Barthelmes H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):581-5. PubMed ID: 4939579
    [No Abstract]   [Full Text] [Related]  

  • 36. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide.
    Hughes GR; Cohen SA; Christian CL
    Ann Rheum Dis; 1971 May; 30(3):259-64. PubMed ID: 4996903
    [No Abstract]   [Full Text] [Related]  

  • 38. Complement and lupus: old concepts and new directions.
    Porcel JM; Vergani D
    Lupus; 1992 Dec; 1(6):343-9. PubMed ID: 1304401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ubiquitinated nuclear proteins and systemic lupus erythematosus].
    Muller S
    Ann Med Interne (Paris); 1991; 142(7):483-5. PubMed ID: 1665026
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA antibodies in the diagnosis and management of SLE.
    Hughes GR
    Clin Sci; 1971 Jun; 40(6):28P. PubMed ID: 5557950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.